|
PPP1R3D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.032220E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.463730E-02 |
| Normal-vs-Stage2 |
1.828440E-01 |
| Normal-vs-Stage3 |
9.89639999999792E-05 |
| Normal-vs-Stage4 |
1.64743999999661E-05 |
| Stage1-vs-Stage2 |
9.259800E-01 |
| Stage1-vs-Stage3 |
2.078300E-02 |
| Stage1-vs-Stage4 |
5.017600E-03 |
| Stage2-vs-Stage3 |
1.306820E-01 |
| Stage2-vs-Stage4 |
1.032770E-01 |
| Stage3-vs-Stage4 |
9.388400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.178100E-04 |
| Normal-vs-AfricanAmerican |
6.43179999999521E-05 |
| Normal-vs-Asian |
8.902200E-02 |
| Caucasian-vs-AfricanAmerican |
1.531960E-01 |
| Caucasian-vs-Asian |
7.693200E-01 |
| AfricanAmerican-vs-Asian |
7.606600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.973400E-04 |
| Normal-vs-Female |
7.415300E-04 |
| Male-vs-Female |
7.616200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.766000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.135200E-03 |
| Normal-vs-Age(61-80Yrs) |
6.0133999999934E-05 |
| Normal-vs-Age(81-100Yrs) |
2.377900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.291800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.447200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.273000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.357390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.376400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.997000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.127000E-01 |
| Normal-vs-Grade 2 |
8.714200E-02 |
| Normal-vs-Grade 3 |
3.28719999997951E-06 |
| Normal-vs-Grade 4 |
2.16340000025461E-07 |
| Grade 1-vs-Grade 2 |
1.946610E-01 |
| Grade 1-vs-Grade 3 |
1.006080E-02 |
| Grade 1-vs-Grade 4 |
2.543800E-03 |
| Grade 2-vs-Grade 3 |
2.496600E-03 |
| Grade 2-vs-Grade 4 |
1.156780E-04 |
| Grade 3-vs-Grade 4 |
4.811500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.175500E-02 |
| Normal-vs-ccB subtype |
3.788500E-04 |
| ccA subtype-vs-ccB subtype |
3.395900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.697050E-03 |
| Normal-vs-N1 |
9.502200E-02 |
| N0-vs-N1 |
6.192200E-01 |
|
|
